A new initiative has been launched in the UAE to support low-income expatriates battling cancer and multiple sclerosis.
They will be provided with medication as part of the Ministry of Health and Prevention's (MOHAP) new agreement with the pharmaceutical firm Merck Serono, and Manzil Healthcare Services.
The programme will benefit patients diagnosed with colorectal, head and neck, and urothelial cancer, as well as multiple sclerosis.
It aims to support those who don't have medical insurance and those with partial coverage.
"The initiative is one of a series of memoranda of understanding signed by the ministry to improve the services provided to low-income patients and secure their access to high-quality medicines," said Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector at MOHAP.
"It will help doctors follow the best practices in the treatment plan, and enable patients to follow up and complete their treatment plan," he added.
Funeral prayer for Sheikh Ahmed bin Rashid to be held on Tuesday
Sheikh Ahmed bin Rashid Al Maktoum passes away; 10-day mourning in Dubai
Abu Dhabi to host UN congress on crime and criminal justice
Abu Dhabi strengthens greenhouse gas emissions monitoring
Sharjah Ruler approves 6,700 housing support requests
Abu Dhabi court secures AED 7.8 million in workers' dues
Sheikh Abdullah to lead UAE delegation at UN General Assembly
UAE sends humanitarian aid to earthquake-hit Colombia
